0      0

241 - Recurrent Urinary Tract Infections

‐ Nov 2, 2014 2:15pm

This discussion covers UTIs in depth, discusses how to deal with UTIs in an era of increasing antibiotic resistance. We are coming into unchartered territory and need to be proactive in the care of our patients. The best way to treat UTIs in the future may be to pre-vent them from happening in the first place.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

Speaker disclosures:

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.


• Differentiate between the female, male and pediatric risk factors for UTIs.
• Discuss the mechanism for the development of ESBLs and CRE.
• Outline appropriate diagnostic workup for recurrent UTIs.


You must be logged in and own this session in order to post comments.